The MicroRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 Receptor and L-type calcium channel-α1C

Hypertension

Volumn 59, Issue 5, 2012, Pages 1006-1013

  Guo, Lei ^a   Qiu, Zhaoping ^a   Wei, Liuping ^a   Yu, Xiufeng ^a   Gao, Xu ^b   Jiang, Shulin ^b   Tian, Hai ^b   Jiang, Chun ^c   Zhu, Daling ^a,b  

^a Department of Biopharmaceutical Sciences   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Hypoxia; MiR 328; Pulmonary hypertension; Vasoconstriction

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL L TYPE ALPHA 1C; LUCIFERASE; MICRORNA; MICRORNA 328; POTASSIUM CHLORIDE; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTERIAL WALL THICKNESS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYMATIC ASSAY; HEART RIGHT VENTRICLE PRESSURE; HYPOXIA; HYPOXIC PULMONARY HYPERTENSION; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BLOCKING; RNA SYNTHESIS; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ANIMALS; ANOXIA; APOPTOSIS; CALCIUM CHANNELS, L-TYPE; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; MICE; MICE, TRANSGENIC; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; VASOCONSTRICTION;

EID: 84863419659     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.185413     Document Type: Article

References (17)

1. Moudgil R, Michelakis ED, Archer SL. Hypoxic pulmonary vasoconstriction. J Appl Physiol. 2005;98:390-403. (Pubitemid 40041273)
2. Keseru B, Barbosa-Sicard E, Schermuly RT, Tanaka H, Hammock BD, Weissmann N, Fisslthaler B, Fleming I. Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition. Cardiovasc Res. 2010;85:232-240.
3. Weissmann N, Grimminger F, Olschewski A, Seeger W. Hypoxic pulmonary vasoconstriction: a multifactorial response? Am J Physiol Lung Cell Mol Physiol. 2001;281:L314-L317. (Pubitemid 32756042)
4. Cuellar TL, McManus MT. MicroRNAs and endocrine biology. J Endocrinol. 2005;187:327-332. (Pubitemid 43020253)
5. Ma C, Li Y, Ma J, Liu Y, Li Q, Niu S, Shen Z, Zhang L, Pan Z, Zhu D. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension. Hypertension. 2011;58:679-688.
6. Ma J, Liang S, Wang Z, Zhang L, Jiang J, Zheng J, Yu L, Zheng X, Wang R, Zhu D. ROCK pathway participates in the processes that 15- hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. J Cell Physiol. 2010; 222:82.
7. Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt S, Ertl G, Bauersachs J. MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure. Circulation. 2007;116: 258-267. (Pubitemid 47196561)
8. Mann DL. MicroRNAs and the failing heart. N Engl J Med. 2007;356: 2644-2645. (Pubitemid 46961011)
9. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol. 2007;170:1831-1840. (Pubitemid 47339258)
10. Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R, Raj JU. MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol. 2010;299: L861-L871.
11. Courboulin A, Paulin R, Giguere NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Cote J, Simard MJ, Bonnet S. Role for miR-204 in human pulmonary arterial hypertension. J Exp Med. 2011;208:535-548.
12. Caruso P, MacLean MR, Khanin R, McClure J, Soon E, Southgate M, MacDonald RA, Greig JA, Robertson KE, Masson R, Denby L, Dempsie Y, Long L, Morrell NW, Baker AH. Dynamic changes in lung microRNA profiles during the development of pulmonary hypertension due to chronic hypoxia and monocrotaline. Arterioscl Throm Vas. 2010;30: 716-723.
13. Hirenallur SD, Haworth ST, Leming JT, Chang J, Hernandez G, Gordon JB, Rusch NJ. Upregulation of vascular calcium channels in neonatal piglets with hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2008;295:L915-L924.
14. Tsuruzoe K, Emkey R, Kriauciunas KM, Ueki K, Kahn CR. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1-and IRS-2-mediated signaling. Mol Cell Biol. 2001;21:26-38.
15. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 1995;16:143-163.
16. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799-806. (Pubitemid 34000783)
17. Stewart CE, Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev. 1996; 76:1005-1026. (Pubitemid 26346814)